DK3957320T3 - Forstærket syre-alfa-glucosidase til behandling af pompes sygdom - Google Patents

Forstærket syre-alfa-glucosidase til behandling af pompes sygdom Download PDF

Info

Publication number
DK3957320T3
DK3957320T3 DK21174249.9T DK21174249T DK3957320T3 DK 3957320 T3 DK3957320 T3 DK 3957320T3 DK 21174249 T DK21174249 T DK 21174249T DK 3957320 T3 DK3957320 T3 DK 3957320T3
Authority
DK
Denmark
Prior art keywords
glucosidase
disease
pump
treatment
acid alpha
Prior art date
Application number
DK21174249.9T
Other languages
English (en)
Other versions
DK3957320T5 (da
Inventor
Hung V Do
Richie Khanna
Russell Gotschall
Original Assignee
Amicus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics Inc filed Critical Amicus Therapeutics Inc
Publication of DK3957320T3 publication Critical patent/DK3957320T3/da
Application granted granted Critical
Publication of DK3957320T5 publication Critical patent/DK3957320T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK21174249.9T 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom DK3957320T5 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562272890P 2015-12-30 2015-12-30
US201662300479P 2016-02-26 2016-02-26
US201662315412P 2016-03-30 2016-03-30
US201662402454P 2016-09-30 2016-09-30
US201662428867P 2016-12-01 2016-12-01
US201662431791P 2016-12-08 2016-12-08
EP16826898.5A EP3397273B1 (en) 2015-12-30 2016-12-29 Augmented acid alpha-glucosidase for the treatment of pompe disease

Publications (2)

Publication Number Publication Date
DK3957320T3 true DK3957320T3 (da) 2023-11-27
DK3957320T5 DK3957320T5 (da) 2024-08-05

Family

ID=60186557

Family Applications (3)

Application Number Title Priority Date Filing Date
DK16826898.5T DK3397273T3 (da) 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom
DK23188938.7T DK4285902T3 (da) 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom
DK21174249.9T DK3957320T5 (da) 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK16826898.5T DK3397273T3 (da) 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom
DK23188938.7T DK4285902T3 (da) 2015-12-30 2016-12-29 Forstærket syre-alfa-glucosidase til behandling af pompes sygdom

Country Status (16)

Country Link
EP (4) EP4706779A2 (da)
CN (1) CN108472340A (da)
CY (1) CY1124637T1 (da)
DK (3) DK3397273T3 (da)
ES (3) ES2883844T3 (da)
FI (2) FI4285902T3 (da)
HK (1) HK1253014A1 (da)
HR (3) HRP20231465T1 (da)
HU (2) HUE054733T2 (da)
LT (3) LT3397273T (da)
PL (3) PL4285902T3 (da)
PT (3) PT3397273T (da)
RS (3) RS64843B1 (da)
SI (3) SI4285902T1 (da)
SM (3) SMT202100452T1 (da)
TW (3) TW202506173A (da)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) * 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
PT2857036T (pt) 2003-01-31 2017-03-13 Mount Sinai School Of Medicine Of N Y Univ Terapia combinada para o tratamento de distúrbios de deficiência proteica
CA2553955C (en) * 2004-02-10 2012-08-28 Zystor Therapeutics, Inc. Acid alpha-glucosidase and fragments thereof
AU2006247065B8 (en) 2005-05-17 2012-07-12 Amicus Therapeutics, Inc. A method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives
WO2009102895A2 (en) 2008-02-12 2009-08-20 Amicus Therapeutics, Inc. Method to predict response to pharmacological chaperone treatment of diseases
WO2010138608A1 (en) * 2009-05-26 2010-12-02 Amicus Therapeutics, Inc. Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
EP2844279B1 (en) 2012-05-03 2020-12-09 Amicus Therapeutics, Inc. Dosing regimens for the treatment of pompe disease
HK1209625A1 (en) 2012-07-17 2016-04-08 Amicus Therapeutics, Inc. Alpha-galactosidase a and 1-deoxygalactonojirimycin co-formulation
CN114540327B (zh) * 2014-09-30 2026-03-24 阿米库斯治疗学公司 具有增强的碳水化合物的高强度酸性α-葡糖苷酶

Also Published As

Publication number Publication date
EP3957320A1 (en) 2022-02-23
EP3397273A1 (en) 2018-11-07
DK3397273T3 (da) 2021-08-09
TW202245831A (zh) 2022-12-01
EP3397273B1 (en) 2021-05-19
TWI849380B (zh) 2024-07-21
EP4706779A2 (en) 2026-03-11
TW202506173A (zh) 2025-02-16
TWI753874B (zh) 2022-02-01
SMT202600054T1 (it) 2026-03-09
PL4285902T3 (pl) 2026-04-13
LT3397273T (lt) 2021-06-25
HUE064049T2 (hu) 2024-02-28
FI4285902T3 (fi) 2026-02-17
SI3957320T1 (sl) 2024-01-31
FI3957320T3 (fi) 2023-11-23
HRP20260120T1 (hr) 2026-03-13
CY1124637T1 (el) 2022-07-22
HRP20231465T1 (hr) 2024-03-01
EP3957320B1 (en) 2023-08-23
PL3397273T3 (pl) 2021-12-06
DK3957320T5 (da) 2024-08-05
LT4285902T (lt) 2026-02-25
CN108472340A (zh) 2018-08-31
TW201726163A (zh) 2017-08-01
HK1253014A1 (zh) 2019-06-06
SMT202300412T1 (it) 2024-01-10
PT3957320T (pt) 2023-11-23
RS62212B1 (sr) 2021-09-30
DK4285902T3 (da) 2026-02-16
PT4285902T (pt) 2026-02-10
RS67727B1 (sr) 2026-03-31
HRP20210894T1 (hr) 2021-07-23
SMT202100452T1 (it) 2021-09-14
RS64843B1 (sr) 2023-12-29
EP4285902B1 (en) 2025-11-19
HUE054733T2 (hu) 2021-09-28
ES3063549T3 (en) 2026-04-17
SI3397273T1 (sl) 2021-11-30
PL3957320T3 (pl) 2024-02-19
EP4285902A2 (en) 2023-12-06
EP4285902A3 (en) 2024-02-21
PT3397273T (pt) 2021-08-09
ES2965190T3 (es) 2024-04-11
ES2883844T3 (es) 2021-12-09
LT3957320T (lt) 2023-12-11
SI4285902T1 (sl) 2026-04-30

Similar Documents

Publication Publication Date Title
IL283837A (en) Augmented acid alpha-glucosidase for the treatment of pompe disease
IL263090A (en) Catheter of a heart pump shaped for anatomic fit
LT3334422T (lt) Kanabidiolio rūgšties panaudojimas epilepsijos gydymui
DK3287155T3 (da) Blodpumpe
DK3386511T3 (da) Fremgangsmåder til behandling af huntingtons sygdom
DK3383363T3 (da) Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande
DK3413948T3 (da) Blodpumpesystem
DK3364997T5 (da) Aspartoacylase genterapi til behandling af canavans sygdom
DK3294345T3 (da) Tpp1-formuleringer og fremgangsmåder til behandling af cln2-sygdom
EP3446728A4 (en) BLOOD PUMP
DE112017004905A5 (de) Blutpumpe
HUE060517T2 (hu) Immunhiányos betegség kezelésére szolgáló eljárások
DK3313816T3 (da) Metabolisk robuste analoger af cyp-eicosanoider til behandling af hjertesygdom
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
LT3251675T (lt) Šlapimo rūgšties (kaupimosi) arba podagros ligos prevencija arba gydymas
DE112015002229A5 (de) Formulierungen zur Behandlung von Hyperthyreose
BR112016015712A2 (pt) método de tratamento de doenças hepáticas.
DK3406258T3 (da) Medikament til anvendelse til behandling af urinsyregigt
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
IL272443A (en) Glycyrrhetinic acid derivatives for treating hyperkalemia
KR101583452B9 (ko) 위장질환 치료용 의약 조성물
ME03056B (me) Jedinjenja 3,4-diamino-6-hloropirazin-2-karboksamida za tretman bolesti posredovanih sa enac
DK3957320T5 (da) Forstærket syre-alfa-glucosidase til behandling af pompes sygdom
EP3226883C0 (en) COMPOSITIONS FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
DK3072509T3 (da) Sammensætninger til behandling af mortellaros sygdom og fremgangsmåder til fremstilling deraf